Association of Clinical Research Organizations, Washington, DC, USA.
Health Aff (Millwood). 2010 Nov;29(11):2082-90. doi: 10.1377/hlthaff.2010.0635.
Current laws, practices, and concerns about privacy inhibit access to health data for research. Barriers include inconsistent Institutional Review Board policies and complicated and costly procedures to obtain the consent of patients for release of their information. To realize the promise of comparative effectiveness research, it is essential to develop a new policy framework that will allow and encourage the use of health information in all forms--fully identifiable, partially anonymized, and deidentified. We propose that health data be made available for information-based research under a so-called research safe harbor. The arrangement would include strict data security controls, standards, and practices to be promulgated by the secretary of health and human services, and an annual third-party audit to ensure compliance.
现行法律、实践和对隐私的关注阻碍了医疗数据用于研究。障碍包括机构审查委员会政策不一致,以及获得患者同意发布其信息的程序复杂且费用高昂。为了实现比较效果研究的承诺,有必要制定一个新的政策框架,允许并鼓励以各种形式使用健康信息——完全可识别、部分匿名和去识别。我们建议在所谓的研究安全港下,使健康数据可用于基于信息的研究。该安排将包括由卫生与公众服务部长颁布的数据安全控制、标准和惯例,并进行年度第三方审计以确保合规性。